Home/ Supplements/ Vitamin K/ Propolis 300

Propolis 300

product on market Tablet or Pill Yamada Bee Company Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile contains essential minerals like potassium and phosphorus, which support cellular function and bone health. Research provides strong evidence for the roles of these nutrients in maintaining systemic homeostasis. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Propolis 300
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
33
Servings
Botanical
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Protein
1 Gram(s)
6 mcg (5% DV)
Within RDA (0.1× RDA) 275 studies (A:9, B:175)
1 mg (1% DV)
Market median: 99.0mg (503 products) 13 studies (A:0, B:3)
Potassium
6 mg (1% DV)
Propolis extract
290 mg

Other Ingredients

Sucrose Fatty Acid Ester Gelatin Glycerin L-Arginine Pectin Cacao extract
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: For adults take 3-6 tablets in a day with a drink of water.

Warnings & Precautions

Caution: Bee products may cause an allergic reaction if symptoms rash, redness, itchiness, difficulty breathing, exists discontinue use and seek immediate medical attention.

Keep out of reach of infants and children.

Warning: If you are pregnant or breast-feeding, have health conditions, or taking other medications, ask a health professional before use.

On rare occasions, itchiness or rash and temporary irritation may occur. Discontinue use immediately if any adverse reactions occur and consult a doctor. Report adverse health events to: The Food and Drug Administration (FDA)

Formulation Notes

Propolis extract

Health Claim: Propolis 300 helps maintain normal cognitive functions from mild memory loss associated with aging. Propolis 300 helps regulate a normal oxidative condition. Propolis 300 supports a healthy response to inflammation. Propolis 300 helps stimulate microglia in the brain.

Product of Japan

Additional Information

Yamada Bee Farm The gifts of nature for better health JHFA [300] 100

Storage: Please avoid direct sunlight, high temperature and humidity. Store in a cool place.

Metadata

Product Details

DSLD Entry Date2020-12-26
Product TypeBotanical
FormTablet or Pill
DSLD ID242220
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.